3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
4
Breast Neoplasms
4
Breast Neoplasms, Male
3
Sarcoma
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Kidney Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Melanoma
1
Liver Neoplasms
1
Liposarcoma
1
Leukemia
1
Hepatitis C
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Interventions
Bevacizumab
112
Fluorouracil
98
Oxaliplatin
96
Leucovorin
96
Irinotecan
86
Capecitabine
73
Cetuximab
64
Panitumumab
42
pembrolizumab
38
regorafenib
28
Nivolumab
23
IFL protocol
22
Folfox protocol
21
trifluridine tipiracil drug combination
14
Radiotherapy
13
durvalumab
11
Gemcitabine
10
Celecoxib
10
tremelimumab
7
binimetinib
7
aflibercept
7
Drug Therapy
7
Disulfides
7
Cyclophosphamide
7
Trifluridine
6
Trastuzumab
6
Sunitinib
6
Paclitaxel
6
Immunoglobulin G
6
Colonoscopy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Colorectal Neoplasms
×
Immunoenzyme Techniques
×
Clear all
No trials found.